A Toxicological Assessment of Creatyl-l-Leucine

Int J Toxicol. Mar/Apr 2018;37(2):171-187. doi: 10.1177/1091581817751142. Epub 2018 Jan 22.

Abstract

A battery of toxicological studies was conducted to investigate the genotoxicity and repeated-dose oral toxicity of creatyl-l-leucine, a synthetic compound, in rats in accordance with internationally accepted guidelines. There was no evidence of mutagenicity in a bacterial reverse mutation test and in an in vitro mammalian chromosomal aberration test. There was no genotoxic activity observed in an in vivo mammalian micronucleus test at concentrations up to the limit dose of 2,000 mg/kg bw/d. Creatyl-l-leucine did not cause mortality or toxic effects in Hsd.Han Wistar rats in a 90-day repeated-dose oral (gavage) toxicity study at doses of 1,250, 2,500, and 5,000 mg/kg bw/d. The no observed adverse effect level from the 90-day study was determined to be 5,000 mg/kg bw/d, the highest dose tested, for both male and female rats.

Keywords: NOAEL; creatyl-l-leucine; safety assessment; toxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Cricetulus
  • Erythrocytes / drug effects
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Female
  • Leucine / analogs & derivatives*
  • Leucine / toxicity*
  • Male
  • Mice
  • No-Observed-Adverse-Effect Level
  • Rats, Wistar
  • Salmonella typhimurium / drug effects
  • Salmonella typhimurium / genetics
  • Toxicity Tests

Substances

  • Leucine